Antihypertensive effects of hydrolysates of wakame (Undaria pinnatifida) and their angiotensin-I-converting enzyme inhibitory activity

Minoru Sato, Takashi Oba, Toshiyasu Yamaguchi, Toshiki Nakano, Takashi Kahara, Katsura Funayama, Akio Kobayashi, Takahisa Nakano

研究成果: Article査読

60 被引用数 (Scopus)

抄録

Aim: The angiotensin-I-converting enzyme (ACE) inhibitory and antihypertensive activities of wakame hydrolysates have been investigated in several studies. Methods: Wakame (Undaria pinnatifida) was hydrolyzed using 17 kinds of proteases and the inhibitory activity of the hydrolysates for ACE was measured. Of these hydrolysates 4 with potent ACE inhibitory activity were administered singly and orally to spontaneously hypertensive rats (SHR). Results: The systolic blood pressure of SHR decreased significantly after single oral administration of protease S 'Amano' and proleather FG-F hydrolysates (10 mg protein/kg body weight). In a long-term feeding experiment, 7-week-old SHR were fed standard chow supplemented with protease S 'Amano'-derived wakame hydrolysates for 10 weeks. In SHR fed the 1 and 0.1% wakame hydrolysates, elevation of systolic blood pressure was still significantly suppressed for 7 weeks. Conclusions: The hydrolysates derived from wakame by protease S 'Amano' have a powerful ACE-inhibitory activity (IC50=86μg protein/ml) and were effective in spite of their slight bitterness as 'physiologically functional food' with antihypertensive activity.

本文言語English
ページ(範囲)259-267
ページ数9
ジャーナルAnnals of Nutrition and Metabolism
46
6
DOI
出版ステータスPublished - 2002

ASJC Scopus subject areas

  • 医学(その他)
  • 栄養および糖尿病

フィンガープリント

「Antihypertensive effects of hydrolysates of wakame (Undaria pinnatifida) and their angiotensin-I-converting enzyme inhibitory activity」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル